Open AccessOutcomes of combination therapy for stage IIA–IIIB cervical cancer
Author(s) -
Damarys Santiago,
А. С. Хаджимба,
I.V. Sobolev,
А. А. Ильин,
С. Я. Максимов
Publication year - 2019
Publication title -
opuholi ženskoj reproduktivnoj sistemy
Language(s) - English
Resource type - Journals
eISSN - 1999-8627
pISSN - 1994-4098
DOI - 10.17650/1994-4098-2018-14-4-50-55
Subject(s) - medicine , cervical cancer , stage (stratigraphy) , chemoradiotherapy , radiation therapy , radical hysterectomy , combination therapy , surgery , hysterectomy , oncology , cancer , biology , paleontology
Objective: to analyze treatment outcomes in patients with stage IIA–IIIB cervical cancer. Materials and methods. The study included 278 women with stage IIA–IIIB cervical cancer. Study participants were divided into 2 groups. Group 1 comprised 165 patients who received chemoradiotherapy + surgery (radical hysterectomy). Patients in group 2 received standard radiotherapy. Results. Patients receiving combination therapy demonstrated better overall and relapse-free survival compared to those receiving standard treatment. Conclusion. Both publications of other authors and our own results suggest high efficacy and safety of combination therapy for stage IIA–IIIB cervical cancer.